CLOVER BIOPHARMACEUTICALS AUS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

First Posted Date
2021-06-09
Last Posted Date
2022-04-19
Lead Sponsor
Clover Biopharmaceuticals AUS Pty Ltd
Registration Number
NCT04919096

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

First Posted Date
2020-12-17
Last Posted Date
2023-06-29
Lead Sponsor
Clover Biopharmaceuticals AUS Pty Ltd
Target Recruit Count
31454
Registration Number
NCT04672395
Locations
🇨🇴

Centro de Estudios en Infectología Pediátrica S.A.S. - CEIP S.A.S., Cali, Colombia

🇵🇭

University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines

🇧🇪

Private Practice RESPISOM Namur, Namur, Belgium

and more 28 locations

SCB-2019 as COVID-19 Vaccine

First Posted Date
2020-05-28
Last Posted Date
2022-02-18
Lead Sponsor
Clover Biopharmaceuticals AUS Pty Ltd
Target Recruit Count
166
Registration Number
NCT04405908
Locations
🇦🇺

Linear Clinical Research Ltd, Nedlands, Western Australia, Australia

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

Phase 1
Completed
Conditions
Malignant Pleural Effusions
Interventions
Drug: SCB-313
First Posted Date
2019-03-11
Last Posted Date
2022-02-02
Lead Sponsor
Clover Biopharmaceuticals AUS Pty Ltd
Target Recruit Count
5
Registration Number
NCT03869697
Locations
🇦🇺

The Royal Melbourne Hospital, Parkville, Victoria, Australia

🇦🇺

Orange Health Service, Orange, New South Wales, Australia

🇦🇺

SCGH (Sir Charles Gairdner Hospital), Nedlands, Western Australia, Australia

and more 1 locations

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies

Phase 1
Completed
Conditions
Peritoneal Malignancies
Interventions
Drug: SCB-313
First Posted Date
2018-02-23
Last Posted Date
2021-10-19
Lead Sponsor
Clover Biopharmaceuticals AUS Pty Ltd
Target Recruit Count
7
Registration Number
NCT03443674
Locations
🇦🇺

Liverpool Hospital, Liverpool, New South Wales, Australia

🇦🇺

Orange Health Service, Orange, New South Wales, Australia

🇦🇺

John Flynn Private Hospital, Tugun, Queensland, Australia

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy